Capital One Financial Corporation reported net income of $1.1 billion or $1.87 per diluted share in the second quarter of 2013, compared with $1.0 billion or $1.79 per diluted share last quarter, and $92 million in second-quarter 2012. Last year’s results reflected significant purchase accounting impacts as Capital One closed the acquisition of HSBC U.S. card business. The largest impact was the larger loan loss … Continue reading COF Sailing Along Into Q3
The oft-trodden path for a startup biotech is to aim for either a buyout or an IPO—or at minimum, a partnership with a big pharmaceutical company—before dealing with the hefty price tag of a Phase 3 study. One local biotech, however, took on the risk of bucking that trend—and succeeded. That story and much more below. Boston and Hayward, CA-based Intarcia turned heads earlier this … Continue reading Biotech Stocks: A Look At the Most Promising Biotech Stocks
Melco Crown Entertainment announced solid second quarter results that were above analysts expectations and consensus estimates. Revenue increased 38% to $1.3 billion (above consensus of $1.2 billion) and adjusted EBITDA increased 62% to $330 million (well above consensus of $283 million), as the company’s City of Dreams casino on the Cotai Strip continued to take share from casinos on the Macau peninsula. Adjusted EBITDA margins … Continue reading Melco Crown Reports Robust Earnings in Second Quarter
Baer’s reported net income for the first half of CHF 114 million includes a significant amount of acquisition, integration, and one-off items. On an underlying basis, the bank’s net profit was CHF 261 million for the first half, up 26% from the year-ago half, as the bank benefited from higher assets under management and increased client activity. The bank’s underlying return on equity was about … Continue reading BAER Finishes Off Strong 2Q
Here we have a close look at some of the major Biotech Stocks which have shown tremendous promise over the past few weeks. Investors are all recommended to closely monitor these stocks over the coming months as some movement is expected from these stocks. Portola Pharmaceuticals (PTLA), a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. This stock closed up 4.1% … Continue reading Biotech Stocks in News: Major Biotech Stocks to Focus On
The People’s Bank of China (PBOC) announced the elimination of the original lending rate floor of 30% discount to benchmark, allowing banks to lend at any discount to benchmark lending rates as they see fit. The PBOC scrapped the cap on lending rates in 2004, and this move will fully liberalize lending rates for banks. Greater pricing flexibility will enable the banks to retain their … Continue reading PBOC Announces Elimination of the Original Lending Rate Floor
